Assembly Biosciences, Inc.

NASDAQ:ASMB

Biotechnology

Healthcare
$22.39 +0.66%

+$0.16 today

Market cap
$458.48M
Beta
1.08
P/E (TTM)
-64.4
EPS (TTM)
-$0.38
52W Low $16.50High $39.71

Volume 0.49M

Average 0.17M

ASMB Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Assembly Biosciences, Inc.NASDAQ: ASMB

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue declines year over year

Q1 FY2026 cost of revenue of $26K fell 99.8% year over year, behind the -62.1% change in trailing-twelve-month cost of revenue. Sequentially, it fell 18.8% from the prior quarter. Over 3 fiscal years it compounded at -87.7% a year.

Context

  • Cost of revenue amounted to 0.2% of revenue in FY2025, down 195.9 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -99.8% toward the trailing-twelve-month pace of -62.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$26K-18.8% QoQ
Last fiscal yearDec 2025
$129K-99.8% YoY
LTMMar 2026
$16.18M-62.1% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-99.8%——
1 year-99.8%——
3-year CAGR-87.7%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
129K USD
Year-over-year change
-99.8%

Cost of Revenue vs competitors

How ASMB compares with its peers on the latest reported figures

  • ASMB's LTM Mar 2026 cost of revenue of $16.18M is the 2nd highest of the 6 companies compared; the peer median is $33K.
  • Its year-over-year change of -62.1% is the 2nd highest of 4, against a peer median of -99.8%.
  • Cost of revenue amounts to 22.8% of revenue for ASMB, versus a peer median of 1.7%.
ASMB Competitors Peer median
Cost of Revenue for ASMB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AVIRAtea Pharmaceuticals, Inc.LTM Mar 2026$40.76M +72.9%——
ASMBAssembly Biosciences, Inc.LTM Mar 2026$16.18M -62.1%-87.7%22.8%
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 2026$1.21M ——1.7%
ABUSArbutus Biopharma CorporationLTM Mar 2026$33K -99.8%—0.0%
INDPIndaptus Therapeutics, Inc.LTM Mar 2026$0 ———
VIRVir Biotechnology, Inc.LTM Mar 2026-$114.78M -122.6%-73.4%175.2%
Peer median (excluding ASMB) $33K-99.8%-73.4%1.7%

Competitors are the stored peer set for ASMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.25M07.16M28.52M72.3M
Cost of Revenue069.08M48.9M55.93M129K
Gross Profit6.25M(69.08M)(41.74M)(27.41M)72.17M
Gross Margin100.0%—-582.7%-96.1%99.8%
Research & Development68.52M69.98M48.9M55.93M64.81M
Selling, General & Admin28.78M23.93M22.91M18.01M19.61M
Operating Expenses138.94M25.03M22.91M18.01M84.42M
Depreciation & Amortization466K498K450K129K129K
EBITDA(90.58M)(92.52M)(60.75M)(39.72M)(5.99M)
EBITDA Margin-1448.4%—-848.0%-139.3%-8.3%
Operating Income(132.69M)(94.11M)(64.65M)(45.42M)(12.12M)
Operating Margin-2121.7%—-902.5%-159.3%-16.8%
Interest Income302K1.02M3.45M5.57M6M
Interest Expense00000
Other Income / Expenses302K1.02M3.45M5.57M6M
Income Before Tax(132.39M)(93.09M)(61.2M)(39.85M)(6.12M)
Pre-Tax Margin-2116.8%—-854.3%-139.7%-8.5%
Income Tax Expense(2.53M)033K330K0
Net Income(129.86M)(93.09M)(61.23M)(40.18M)(6.12M)
Net Margin-2076.4%—-854.8%-140.9%-8.5%
EPS (Basic)(36.00)(22.82)(13.38)(6.69)(0.55)
EPS (Diluted)(36.00)(22.82)(13.38)(6.69)(0.55)
Weighted Avg Shares3.61M4.03M4.58M6M11.21M
Weighted Avg Shares (Diluted)3.61M4.03M4.58M6M11.21M

Assembly Biosciences, Inc.

NASDAQ:ASMB

Intrinsic Alpha fair value

Locked

Current Price

$22.39

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.